Home » Topics » Regulatory » Patents

Patents
RSS

Orally active inhibitors of tumor neovascularization described by Mercian

Jan. 28, 1999

Novel cognition-enhancing agents designed at MS&D

Jan. 28, 1999

SB patents new cathepsin K inhibitors

Jan. 28, 1999

Novel triptolide derivatives from HMR for rheumatoid arthritis and other autoimmune diseases

Jan. 28, 1999

Nicotinic acetylcholine receptor agonists emerge from Sumitomo R&D

Jan. 28, 1999

Yoshitomi's new immunosuppressive agents for arthritis, autoimmune diseases and transplant rejection

Jan. 27, 1999

Ligand inhibitors of CRF/CRF-binding protein complex reported by Lilly

Jan. 27, 1999

Neuronal Ca2+ channel-blocking peptides in development at Mitsubishi

Jan. 27, 1999

Canadian pharmaceutical and academic research team discovers new benzoporphyrins for PDT

Jan. 27, 1999

Potent ACAT inhibitors for lipid disorders from Sankyo

Jan. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...